BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sampietro A, Pérez-areales FJ, Martínez P, Arce EM, Galdeano C, Muñoz-torrero D. Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis. Pharmaceuticals 2022;15:545. [DOI: 10.3390/ph15050545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Karger E, Kureljusic M. Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda. Pharmaceuticals 2022;15:1492. [DOI: 10.3390/ph15121492] [Reference Citation Analysis]
2 Rehman MU, Sehar N, Dar NJ, Khan A, Arafah A, Rashid S, Rashid SM, Ganaie MA. Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments. Neuroscience & Biobehavioral Reviews 2022. [DOI: 10.1016/j.neubiorev.2022.104961] [Reference Citation Analysis]
3 Álvarez-berbel I, Espargaró A, Viayna A, Caballero AB, Busquets MA, Gámez P, Luque FJ, Sabaté R. Three to Tango: Inhibitory Effect of Quercetin and Apigenin on Acetylcholinesterase, Amyloid-β Aggregation and Acetylcholinesterase-Amyloid Interaction. Pharmaceutics 2022;14:2342. [DOI: 10.3390/pharmaceutics14112342] [Reference Citation Analysis]
4 Feng X, Hadizadeh M, Zheng L, Li W. A Bibliometric and Visual Analysis of Exercise Intervention Publications for Alzheimer’s Disease (1998–2021). JCM 2022;11:5903. [DOI: 10.3390/jcm11195903] [Reference Citation Analysis]
5 Jastrzębska-więsek M, Kotańska M, Grzeszczak A, Jaromin A, Walczak M, Partyka A, Gdula-argasińska J, Smolik M, Zagórska A. The Antidepressant-like Activity, Effects on Recognition Memory Deficits, Bioavailability, and Safety after Chronic Administration of New Dual-Acting Small Compounds Targeting Neuropsychiatric Symptoms in Dementia. IJMS 2022;23:11452. [DOI: 10.3390/ijms231911452] [Reference Citation Analysis]
6 Czarnota-Łydka K, Kucwaj-Brysz K, Pyka P, Haberek W, Podlewska S, Handzlik J. Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer's Disease: Can It Work from a Molecular Point of View? Int J Mol Sci 2022;23:8768. [PMID: 35955902 DOI: 10.3390/ijms23158768] [Reference Citation Analysis]